newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Reports Annual Financial Results for 2020 and Provides Updated Business Review

TORRANCE, Calif., May 4, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC:EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, announced today its financial results for the year ended December 31, 2